MINA Human (A60406)

MINA Human

MYC Induced Nuclear Antigen Human Recombinant

Escherichia Coli.

MGSSHHHHHH SSGLVPRGSHMPKKAKPTGS GKEEGPAPCK QMKLEAAGGP SALNFDSPSS LFESLISPIK TETFFKEFWE QKPLLIQRDD PALATYYGSLFKLTDLKSLC SRGMYYGRDV NVCRCVNGKK KVLNKDGKAH FLQLRKDFDQ KRATIQFHQP QRFKDELWRIQEKLECYFGSLVGSNVYITP AGSQGLPPHY DDVEVFILQL EGEKHWRLYH PTVPLAREYSVEAEERIGRP VHEFMLKPGD LLYFPRGTIH QADTPAGLAH STHVTISTYQ NNSWGDFLLD TISGLVFDTAKEDVELRTGI PRQLLLQVES TTVATRRLSG FLRTLADRLE GTKELLSSDM KKDFIMHRLPPYSAGDGAEL STPGGKLPRLDSVVRLQFKD HIVLTVLPDQ DQSDETQEKM VYIYHSLKNS RETHMMGNEE ETEFHGLRFP LSHLDALKQI WNSPAISVKDLKLTTDEEKE SLVLSLWTEC LIQVV.

Greater than 90.0% as determined by SDS-PAGE.

MINA protein solution (0.25mg/ml) containing 20mM Tris-HClbuffer (pH 8.0), 0.15M NaCl, 10% glycerol and 1mM DTT.

Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.

60S ribosomal protein L27a histidine hydroxylase, Bifunctional lysine specific demethylase and histidyl hydroxylase MINA, FLJ14393, Histone lysine demethylase MINA, MDIG, MINA53, MINA_HUMAN, Mineral dust-induced gene protein, MYC induced nuclear antigen, Myc induced nuclear antigen 53 kDa, MYC-induced nuclear antigen, NO52, Nucleolar protein 52, Ribosomal oxygenase MINA, ROX